Deciphera Pharmaceuticals, Inc. (DCPH): Price and Financial Metrics
DCPH Price/Volume Stats
| Current price | $25.59 | 52-week high | $25.61 |
| Prev. close | $25.57 | 52-week low | $9.90 |
| Day low | $25.56 | Volume | 1,596,000 |
| Day high | $25.61 | Avg. volume | 1,292,551 |
| 50-day MA | $21.27 | Dividend yield | N/A |
| 200-day MA | $15.80 | Market Cap | 2.21B |
DCPH Stock Price Chart Interactive Chart >
Deciphera Pharmaceuticals, Inc. (DCPH) Company Bio
Deciphera Pharmaceuticals LLC develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. Its product pipeline includes Altiratinib (DCC-2701), a MET/TIE2/VEGFR2/TRK kinase inhibitor; DCC-2618, a pan-KIT inhibitor; Rebastinib, a TIE2/VEGFR1 kinase inhibitor; and LY3009120 (DP-4978), a pan-RAF inhibitor. The company was founded in 2003 and is based in Waltham, Massachusetts.
DCPH Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DCPH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 0.16% |
| 3-year | 113.96% |
| 5-year | -53.63% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | -1.59% |
| 2022 | 67.76% |
| 2021 | -82.88% |
| 2020 | -8.31% |